Prospective, multi‑center non-randomized single arm phase II study.
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Sirolimus (Primary)
- Indications Arteriovenous fistula
- Focus Therapeutic Use
- Sponsors Vascular Therapies
- 17 Nov 2017 Results published in the Vascular Therapies company website (http://www.vasculartx.com/progress-to-date/)
- 17 Nov 2017 New trial record
- 09 Nov 2017 Results published in the Vascular Therapies media release.